Relationship Between Otorhinolaryngologic Diseases and Obesity
Tae Hyun Kim1, Ho Min Kang1, In-Hwan Oh2
1Department of Otorhinolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, Korea.
Clinical and Experimental Otorhinolaryngology
|September 3, 2015
Summary
Obesity is linked to higher rates of chronic otitis media, chronic rhinosinusitis, and chronic tonsillitis. This study found elevated obesity prevalence and BMI in patients with these common ear, nose, and throat conditions.
Area of Science:
- Otorhinolaryngology
- Public Health
- Epidemiology
Background:
- Global obesity rates are rising, contributing to various health issues.
- Obesity is a significant risk factor for numerous diseases.
- The link between obesity and specific otorhinolaryngologic diseases requires further investigation.
Purpose of the Study:
- To determine the association between obesity and chronic otitis media (COM).
- To investigate the relationship between obesity and chronic rhinosinusitis.
- To examine the connection between obesity and chronic tonsillitis.
Main Methods:
- Comparison of mean body mass index (BMI) between patients with COM, rhinosinusitis, tonsillitis, and a control group.
- Assessment of the prevalence of overweight and obesity in relation to morbidity and BMI.
- Statistical analysis to identify significant differences between groups.
Main Results:
- Mean BMIs were significantly higher in patients with COM, rhinosinusitis, and tonsillitis compared to controls (P<0.05).
- Obesity rates were significantly elevated in the COM (37.5%), rhinosinusitis (42.9%), and tonsillitis (40.1%) groups versus the control group (24.3%, P<0.05).
- No significant difference in overweight rates was observed between patient groups and the control group (P>0.05).
Conclusions:
- Elevated mean BMI and obesity prevalence are associated with chronic otitis media.
- Increased obesity is linked to chronic rhinosinusitis.
- Higher prevalence of obesity is observed in patients with chronic tonsillitis.
Related Concept Videos
01:24Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
01:21Drug Dosing: Obese Patients
341
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
385
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
385
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
284
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
284
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K
01:17Other Pulmonary Disorders
2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K